Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy

• Shannon M. Lenz ,

  Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: slenz@hrsa.gov (SML); ladams@hrsa.gov (LBA)

  Affiliation IHRC, Inc. Atlanta, Georgia, United States of America

  http://orcid.org/0000-0001-5705-1819

  ⨯
• Jaymes H. Collins,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Programs–Laboratory Research Branch, Baton Rouge, Louisiana, United States of America

  http://orcid.org/0000-0001-7509-0109

  ⨯
• Nashone A. Ray,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Programs–Laboratory Research Branch, Baton Rouge, Louisiana, United States of America

  ⨯
• Deanna A. Hagge,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Mycobacterial Research Laboratories, Anandaban Hospital, The Leprosy Mission Nepal, Kathmandu, Nepal

  http://orcid.org/0000-0002-3792-2266

  ⨯
• Ramanuj Lahiri,

  Roles Formal analysis, Funding acquisition, Writing – review & editing

  Affiliation Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Programs–Laboratory Research Branch, Baton Rouge, Louisiana, United States of America

  ⨯
• Linda B. Adams

  Roles Conceptualization, Formal analysis, Funding acquisition, Writing – review & editing

  * E-mail: slenz@hrsa.gov (SML); ladams@hrsa.gov (LBA)

  Affiliation Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Programs–Laboratory Research Branch, Baton Rouge, Louisiana, United States of America

  http://orcid.org/0000-0001-6265-3531

  ⨯